Colorado State University Pueblo continued its ongoing Institute of Cannabis Research webinar series, this time with Ziva Cooper in the spotlight.
Colorado State University Pueblo continued its regular cannabis series with a session tackling compliance in federal cannabis research.
On Friday, the US Drug Enforcement Administration said it is “nearing the end of its review” of applications, some of which have been awaiting action from the federal agency since 2016.
The National Institute on Drug Abuse announced that a “standard THC unit” will be 5 milligrams, marking the first federal definition of a cannabis “dose” for researchers.
Still, there are areas of “promise,” according to an Oregon Health & Science University hosted Neurology Grand Rounds discussion last week.
New NIDA Study Finds Cannabis Use Disorder Association With Poorer Birth Outcomes, Some “Significant”
NIDA director Nora Volkow told Cannabis Wire, “With the data that we have, we can put in a strong recommendation about not smoking marijuana during pregnancy.”
“You get the same percentage of cannabis use disorder within one year for young people of what it takes three years for a young adult,” Nora Volkow, study author and director of NIH’s National Institute on Drug Abuse, told Cannabis Wire.
Since January, when the count was nearly fifty, another eight applications were submitted to the Drug Enforcement Administration for long-awaited licenses to grow federally-legal cannabis for research.
The FDA’s work on CBD, a drop in military members testing positive for cannabis, and other cannabis-related topics were on the agenda at a federal Drug Testing Advisory Board meeting this week.
Until now, in the US, only one entity has been federally approved to cultivate cannabis for research. The DEA will soon issue additional licenses. Here’s who wants in.
Men of color were most often issued criminal summonses for cannabis possession in 2019, according to a new report from Data Collaborative for Justice.
NCI hosted researchers and officials from federal agencies, including the Food and Drug Administration, and the National Institute on Drug Abuse.
Four years after it first announced it would approve federally-licensed cannabis researchers, the DEA has finalized the details. Major entities, like Battelle, are already interested.
The Agency for Healthcare Research and Quality, within the Department of Health and Human Services, is conducting a systematic review on plant-based treatments for chronic pain.
The deputy director of the NIH’s National Center for Complementary and Integrative Health spoke as part of an ongoing cannabis research series at Colorado State University Pueblo.
The grants, awarded by the state’s Bureau of Cannabis Control, come from cannabis tax revenue.